Myeloid Therapeutics is based in Cambridge, MA. It has raised $195M in total funding. Latest round: Series A.
Myeloid Therapeutics is based in Cambridge, MA. Myeloid Therapeutics has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for Myeloid Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners, Moore Strategic Ventures, 8VC, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Every Myeloid Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026